In 1994 Ben van Hout introduced the concept of the cost effectiveness acceptability curve (CEAC). In the 25 years since, the CEAC has become a standard part of health economic evaluations and incorporated into health technology assessment guidelines. Professors Nancy Devlin and Andrew Briggs spoke at a reception at ISPOR Europe this year to celebrate these contributions. As 2019 comes to a close, OHE reflects on 25 years of the CEAC.
OHE presented at the Global AMR R&D Hub Board of Members Meeting in Paris, on adapting HTA and payment mechanisms to incentivise new drugs to tackle AMR. This presentation was based on research by OHE, funded by the Wellcome Trust.
OHE has been awarded a 3-year research grant by the Health Foundation’s Efficiency Research Programme to define an accurate measure of labour productivity in primary care and to identify its determinants, including workforce skill mix, technology and patient characteristics.
The Office of Health Economics wishes to recruit a well-qualified, highly motivated and energetic economist with an industrial organisation background applied to the health care sector, health care systems and/or the life sciences industry.
New research by the Office of Health Economics (OHE) concludes the proposed International Price Index effectively outsources pharmaceutical policy decisions to countries that “give the government a central role” vs. the U.S.’ greater reliance on the private market.